Favorites Sign in

One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
  1. Home
  2. Companies
  3. Ocean Bio-Chem
  4. Financial Ratios
Ocean Bio-Chem logo
Ocean Bio-Chem OBCI
report update icon

Quarterly report 2022-Q2
added 05-23-2026

Ocean Bio-Chem Financial Ratios 2021-2009 | OBCI

Brief overview of Ocean Bio-Chem's financial ratios

This overview follows the five latest available observations from 2017 through 2021.

The latest available valuation ratios are P/E 9.81x (median 11.81x), EV/EBITDA 6.69x (median 8.07x), P/S 1.28x (median 1.09x). Ratios sit near their own comparison base, with an average deviation of 0% from five-year medians.

The inverse P/E implies an earnings yield of 10.2%. This is not a dividend yield, but current earnings relative to market price.

Returns on assets and capital are represented by ROE 17.7%, ROA 13.9%, ROCE 22.9%. Current resource returns are convincing and help explain a higher market valuation.

Current PEG is 0.32x; the market pays comparatively little per unit of expected growth.

Overall assessment

Ocean Bio-Chem's multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.

Annual Financial Ratios Ocean Bio-Chem

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

P/E

 9.8 10.2 13.2 11.8 13.1 17.1 35.5 19.9 15.4 9.3 8.1 - -

P/S

 1.3 1.8 1.1 0.8 0.9 19.4 7.9 20.8 12.3 12.3 11.0 - -

EPS

 0.9 1.0 0.4 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.3 0.3 -

EV (Enterprise Value)

 82.6 M 95.1 M 47.7 M 39.4 M 38.8 M 34.9 M 17.1 M 41.7 M 23.5 M 21.3 M 24.7 M 5.89 M -495 K

EBITDA per Share

 1.3 1.43 0.63 0.53 0.5 0.45 0.19 0.44 0.36 0.46 0.56 0.51 -

EV/EBITDA

 6.7 7.0 8.1 8.1 8.4 8.6 10.3 10.8 7.6 5.6 5.5 1.5 -

PEG

 0.32 0.17 0.57 0.49 0.72 1.37 -2.76 0.58 -0.6 -0.5 0.48 - -

P/B

 1.7 2.5 1.5 1.2 1.4 1.6 0.8 2.0 1.2 1.1 1.4 - -

P/CF

 15.0 15.8 7.7 27.1 11.7 11.9 20.1 22.8 8.8 6.6 31.3 - -

ROE %

 17.72 24.10 11.38 10.19 10.46 9.31 2.23 10.22 8.00 12.13 17.40 18.55 -

ROA %

 13.94 20.08 9.14 7.93 8.14 8.16 1.93 8.54 6.55 9.34 12.04 11.41 -

ROCE %

 22.89 27.52 13.01 11.51 12.62 13.59 3.51 14.41 11.78 17.18 23.30 29.87 -

Current Ratio

 4.7 6.0 5.1 4.5 4.5 8.1 7.4 6.1 5.5 4.6 3.4 2.7 -

DSO

 50.7 50.8 55.2 46.4 47.6 988.8 874.4 864.4 730.9 674.4 499.7 - -

DIO

 136.8 129.4 148.1 4611.2 4640.1 135.0 127.6 135.8 123.3 165.5 167.4 - -

DPO

 22.1 17.2 17.2 714.6 871.3 21.4 17.8 24.1 17.0 25.6 20.2 - -

Operating Cycle

 187.6 180.2 203.4 4657.5 4687.7 1123.8 1002.0 1000.1 854.2 839.9 667.0 - -

Cash Conversion Cycle

 165.5 163.0 186.1 3942.9 3816.3 1102.5 984.2 976.0 837.2 814.3 646.8 - -

All numbers in USD currency

Quarterly Financial Ratios Ocean Bio-Chem

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 - - -0.03 0.14 - 0.34 0.27 0.2 - 0.49 0.37 0.07 - 0.12 0.11 0.08 - 0.14 0.12 0.06 - 0.09 0.1 0.06 - 0.17 0.07 -0.06 - 0.03 0.01 - - 0.1 0.05 0.03 - 0.07 0.02 0.04 - 0.09 0.04 0.04 - 0.14 0.05 0.08

EBITDA per Share

 - - 0.06 0.22 - 0.56 0.43 0.3 - 0.74 0.54 0.11 - 0.26 0.21 0.14 - 0.27 0.22 0.1 - 0.22 0.21 0.11 - 0.32 0.17 -0.06 - 0.13 0.07 0.02 - 0.22 0.11 0.06 - 0.18 0.08 0.08 - 0.2 0.12 0.1 - 0.28 0.13 0.16

ROE %

 8.99 8.99 14.91 20.17 17.49 29.45 32.48 28.56 23.97 27.71 19.27 11.83 9.84 14.45 15.03 13.62 11.04 14.51 13.96 11.83 9.73 16.65 16.42 9.60 7.41 8.85 2.48 -0.84 1.92 6.55 7.31 8.00 8.08 11.59 7.97 7.88 6.63 11.57 10.51 12.07 9.96 18.41 16.64 18.90 16.33 8.45 3.16 4.71

ROA %

 6.78 6.78 11.57 15.78 13.69 22.98 25.47 22.25 18.53 21.41 14.83 9.11 7.54 10.67 10.96 9.84 7.89 10.37 10.73 9.40 7.80 13.42 13.64 7.91 6.08 7.22 2.07 -0.70 1.54 5.23 5.90 6.42 6.48 9.11 6.21 6.05 5.06 8.38 7.54 8.52 6.88 11.63 10.23 11.70 9.93 4.75 1.93 3.26

ROCE %

 11.72 11.72 19.38 26.01 22.58 37.96 41.77 36.31 30.37 35.27 24.51 15.18 12.98 19.09 19.84 17.92 14.47 19.60 19.46 17.03 14.32 24.32 24.18 14.02 10.79 12.96 3.84 -1.14 3.04 9.88 10.83 11.92 11.93 17.55 12.32 12.37 10.40 17.93 16.49 19.27 16.10 28.19 25.92 29.25 24.86 12.09 5.26 7.51

Current Ratio

 - - 3.8 4.6 4.7 3.9 5.2 5.3 6.0 4.5 4.3 4.7 5.1 4.3 4.4 4.1 4.5 3.1 3.7 4.1 4.5 3.5 7.1 6.1 8.1 5.3 6.0 5.3 7.4 4.8 5.9 5.8 6.1 5.0 5.8 5.1 5.5 4.2 4.8 4.7 4.6 3.2 3.9 3.3 3.4 2.4 2.7 3.4

DSO

 - - 65.5 70.9 - 63.5 66.9 64.9 - 69.3 55.9 79.0 - 68.6 63.6 62.1 - 68.8 56.3 554.6 - 2806.7 933.4 593.1 - 2598.6 957.8 767.3 - 2677.2 693.5 524.4 - 1015.4 1111.3 472.4 - 1235.3 688.1 594.5 - 1049.1 714.6 42.7 - 41.5 33.7 -

DIO

 - - 201.6 209.8 - 109.0 167.9 161.4 - 105.1 131.5 204.0 - 130.1 171.8 198.4 - 114.6 136.0 160.7 - 123.0 165.3 162.9 - 110.9 161.3 177.4 - 115.9 157.2 209.5 - 111.7 - - - - - - - - - - - - - -

DPO

 - - 32.9 35.7 - 30.5 40.3 30.1 - 26.5 24.5 29.7 - 22.7 21.8 24.7 - 31.3 30.3 31.5 - 30.3 38.8 35.2 - 29.9 35.3 33.6 - 25.3 27.9 39.5 - 25.0 - - - - - - - - - - - - - -

Operating Cycle

 - - 201.6 280.8 - 172.5 234.8 226.2 - 144.8 179.9 294.2 - 159.7 195.1 238.7 - 166.4 208.8 236.4 - 149.0 194.5 208.7 - 144.3 206.9 240.3 - 142.2 182.7 259.9 - 150.6 50.2 71.4 - 38.6 49.2 53.1 - 26.1 33.9 41.8 - 23.7 28.5 -

Cash Conversion Cycle

 - - 185.9 245.1 - 142.0 194.5 196.2 - 127.5 157.4 264.8 - 147.9 180.2 218.4 - 150.9 188.9 208.7 - 127.0 164.9 179.8 - 125.4 179.6 213.0 - 128.3 164.7 230.7 - 131.4 50.2 71.4 - 38.6 49.2 53.1 - 26.1 33.9 41.8 - 23.7 28.5 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Ocean Bio-Chem, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Conglomerates industry

Issuer Price % 24h Market Cap Country
Matthews International Corporation Matthews International Corporation
MATW
 		$ 19.65 -0.15 % $ 611 M usaUSA
Steel Partners Holdings L.P. Steel Partners Holdings L.P.
SPLP
 		- 0.57 % $ 756 M usaUSA
Alpha Metallurgical Resources Alpha Metallurgical Resources
AMR
 		$ 157.67 1.62 % $ 2.05 B usaUSA
Cemtrex Cemtrex
CETX
 		$ 0.59 -4.86 % $ 78.1 K usaUSA
India Globalization Capital India Globalization Capital
IGC
 		$ 0.2 -4.11 % $ 17.8 M usaUSA
NN NN
NNBR
 		$ 3.05 -1.46 % $ 151 M usaUSA
Seaboard Corporation Seaboard Corporation
SEB
 		$ 3 777.11 -0.18 % $ 3.64 B usaUSA
Tejon Ranch Co. Tejon Ranch Co.
TRC
 		$ 17.59 -0.9 % $ 473 M usaUSA
SGOCO Group, Ltd. SGOCO Group, Ltd.
SGOC
 		- -0.32 % $ 718 M chinaChina
Compass Diversified Compass Diversified
CODI
 		$ 11.94 0.67 % $ 898 M usaUSA
Icahn Enterprises L.P. Icahn Enterprises L.P.
IEP
 		$ 5.08 4.64 % $ 3.84 B usaUSA